Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
SCN4A Gene Paramyotonia congenita of von Eulenburg NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
CACNA1A Gene Spinocerebellar ataxia type 6, autosomal dominant NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
CACNA1A Gene Episodic ataxia type 2 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
CACNA1A Gene Familial hemiplegic migraine type 1 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 199 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 5 | 5 |
|
Comprehensive Epilepsy Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 318 |
|
Hemiplegic Migraine Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 2 | 9 |
|
Spinocerebellar Ataxia Panel (SCA1,2,3,6, and 7) Center for Genetics at Saint Francis Saint Francis Hospital United States | 5 | 5 |
|
SCA Panel (SCA1, 2, 3, 6, 7) test Neurogenetics Cyprus Institute of Neurology and Genetics Cyprus | 5 | 5 |
|
A1a voltage-dependent calcium channel subunit (CACNA1A) gene CAG triplet repeat test Neurogenetics Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Eugenomic S.L. Spain | 145 | 21 |
|
CACNA1A - repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
CACNA1A - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.